Model
Edge
PhaseBio Pharmaceuticals Inc
0001431872
Filing Type
4
Filing Date
5/19/2022
Updated
5/20/22, 10:44 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership